Labshake search

Citations for ACEA Biosciences :

1 - 5 of 5 citations for Mouse anti Rift Valley Fever Virus Nucleoprotein M980 since 2019

Citations are collected from bioRxiv only, the total number of publications could be much larger.

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition

Kevin J. Kramer, et al., bioRxiv - Immunology 2021

Quote: ... values at the endpoint (48 h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences Inc.). Results are expressed as percent neutralization in a presence of respective antibody relative to control wells with no CPE minus CI values from control wells with maximum CPE ...
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking

Andrea R. Shiakolas, et al., bioRxiv - Immunology 2021

Quote: ... values at the endpoint (48 h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences Inc.). Results are expressed as percent neutralization in a presence of respective antibody relative to control wells with no CPE minus CI values from control wells with maximum CPE ...
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Naveenchandra Suryadevara, et al., bioRxiv - Immunology 2021

Quote: ... values at the endpoint (48 h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences Inc.). Results are expressed as percent neutralization in a presence of respective mAb relative to control wells with no CPE minus CI values from control wells with maximum CPE ...
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

Elaine C. Chen, et al., bioRxiv - Immunology 2021

Quote: ... values at the endpoint (48 h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences Inc.). Results are expressed as percent neutralization in a presence of respective mAb relative to control wells with no CPE minus CI values from control wells with maximum CPE ...
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine

Kevin J. Kramer, et al., bioRxiv - Immunology 2021

Quote: ... values at the endpoint (48 h after incubation with the virus) were determined using the RTCA software version 2.1.0 (ACEA Biosciences Inc.). Results are expressed as percent neutralization in a presence of respective plasma/serum relative to control wells with no CPE minus CI values from control wells with maximum CPE ...

Feedback